Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120897173 | 12089717 | 3 | F | 20160614 | 20160218 | 20160708 | PER | US-PFIZER INC-2016087006 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120897173 | 12089717 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, DAILY (12.5 MG, TAKE 4 CAPSULE BY MOUTH DAILY) | U | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 120897173 | 12089717 | 2 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 120897173 | 12089717 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120897173 | 12089717 | 1 | Renal cell carcinoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120897173 | 12089717 | Dysgeusia | |
| 120897173 | 12089717 | Fatigue | |
| 120897173 | 12089717 | Nausea | |
| 120897173 | 12089717 | Oral pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |